Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Helios Two Transaction

15 Jun 2016 07:50

RNS Number : 2335B
Highlands Natural Resources PLC
15 June 2016
 

Highlands Natural Resources plc ("Highlands" or "the Company")

Helios Two Transaction

 

Highlands, the London listed natural resources company, is pleased to announce that it has reached a heads of terms with London listed Opera Investments Plc ("Opera") by which Opera will acquire all of the issued share capital of Highlands' subsidiary, Highlands Helium Development Limited, the owner of Highlands' Helios Two helium and natural gas project in Montana, USA..

 

Background

 

Opera was listed in April 2015 in order to undertake one or more acquisitions of target companies or businesses in the natural resources sector within a defined investment strategy.

 

Opera and Highlands have conditionally agreed that Opera will acquire all of the issued share capital of Highlands Helium Development Limited which owns Highlands' Helios Two helium and natural gas project in Montana, USA for a consideration of approximately £4.0 million (the "Acquisition"). The heads of terms provide that the Acquisition will be satisfied by the issuance of new ordinary shares of £0.01 each in Opera ("Opera Shares") to Highlands at a price of £0.15 per Opera Share (the "Consideration Shares"), valuing the existing issued share capital of Opera at £2.5 million. In addition, it is envisaged that, in conjunction with completion of the Acquisition, there will be an equity financing raising net proceeds of not less than US$750,000 to fund certain future investment and working capital requirements of Helios Two. The heads of terms also stipulate that Opera will reimburse Highlands all of the professional costs incurred by Highlands on this project as well as any costs of further leases that could be acquired for the project (with any such further leases also being the subject of the Acquisition).

 

Both parties believe that the Helios Two assets represent a significant opportunity to take advantage of a potentially significant helium resource, at a time of global concerns around helium scarcity and helium price increases. It is the intention to establish a team dedicated to the development and commercialisation of the Helios Two project, which consists of exploration licences covering 59,033.82 acres in Custer, Carter and Fallon Counties, Montana. Numerous shows of gas have been encountered across the Helios Two target region. Historic gas analysis confirmed the gas contains elevated concentrations of helium (0.36 per cent) similar to the producing US Hugoton helium field, which is the largest natural accumulation of helium in the United States. Consequently, Highlands and Opera believe that a significant volume of gas containing helium could exist in this region which, if correct, would represent a significant helium resource in North America. Highlands has commissioned RPS Knowledge Reservoir to prepare a competent person's report in this regard.

 

Helium

 

The United States Bureau of Land Management (BLM) sold helium for US$104.00 per thousand cubic feet in 2015 compared to current natural gas prices of approximately US$2.40 per thousand cubic feet. Privately negotiated sales of Grade A helium priced for approximately $200.00 per thousand cubic feet in 2015 according to the United States Geological Survey (USGS). Due to worldwide demand, Highlands believes that helium prices could rise significantly. The strong price environment is due to dwindling helium resources which could lead to potential shortages of helium feedstocks globally. The Federal Helium Reserve at the Cliffside Gas Field near Amarillo, Texas was established in 1925 to conserve scarce helium resources and the helium refining capacity connected to it currently requires approximately 2.3 billion cubic feet per annum, representing around 30% of global supply. However, the Federal Helium Reserve's extensive resources are expected to become significantly depleted if not exhausted by 2020, meaning that the requirement to develop new fields into production is strong.

 

Helium is an essential feedstock for numerous industrial, medical, scientific and commercial applications including nuclear power generation, magnetic resonance imaging ('MRI'), industrial fabrication and welding, fundamental sciences and research, fiber optics, space and defence applications, semiconductor manufacturing, and many other applications. Significantly, helium currently has no substitute in cryogenic applications requiring temperatures below -220 degrees Celsius. Highlands believes that helium's role as a critical and presently irreplaceable component of numerous modern industries will underpin future global demand.

 

Highlands CEO Robert Price said, "This transaction reflects Highlands' intention to generate value for shareholders from its exciting asset base in tandem with focussing on its DT Ultravert business that is looking to transform the global re-fracking business. As a result of this transaction, Highlands would become majority shareholder in a company developing a potentially significant helium and natural gas business precisely as global concerns around helium scarcity rise. Highlands has been able to develop the Helios Two project extremely efficiently, and now Highlands' shareholders can benefit from value creation without any capital commitments.

 

"We are excited to work with the Opera team. We have been impressed with Opera's management throughout the negotiation and preliminary diligence process and together, we believe that the development Helios Two can generate significant value for shareholders of both companies."

 

Opera Chairman Paul Dudley said. "These heads of terms with Highlands move Opera one important step closer to acquiring a valuable development-ready asset. Given broad concerns around helium scarcity and price increases, the Opera management team views the Helios Two assets as a highly compelling development opportunity that fits well with its existing strategy and core competencies. This transaction has the potential to position Opera as one of the only publicly-traded investment vehicles offering shareholders dedicated exposure to helium assets. Together with Highlands' management and advisors, we feel well-equipped to develop and commercialise the Helios Two project and to deliver value to shareholders."

 

The Acquisition remains conditional on a number of matters, including:

 

· The Acquisition will be considered a reverse takeover for Opera in accordance with the FCA Listing Rules and, consequently, will be subject to the publication of a prospectus by Opera and its shareholders' approval.

 

· New directors will be appointed to the board of Opera including, in particular, a non-executive director with experience of helium. In due course, but expected to be after completion of the Acquisition, Opera also expects to appoint a chief executive who is experienced in this industry. Highlands and Opera will also enter into a relationship agreement pursuant to which, amongst other things, Highlands will be entitled to nominate two directors to the Opera board.

 

· At the time of announcing the full terms of the Acquisition, Opera will also carry out a fundraising by way of the issue of new ordinary shares in Opera (the "Fundraising"), the purpose of which will be to put the company in funds to carry out the first stage of the development plan for Helios Two, namely the drilling of the first two wells and their associated injection well.

 

· Following the issue of the Consideration Shares, Highlands will be a majority shareholder in Opera and, accordingly, the Acquisition will be subject to a Takeover Code whitewash (the "Whitewash") and Opera shareholder approval in respect of the provisions of Rule 9 of the Takeover Code. Details of the Whitewash will be contained in Opera's prospectus.

 

· Finally, the Acquisition will be subject to conclusion of the parties' due diligence, and the parties entering into final documentation including an acquisition agreement. It is expected that for the first 12 months following the Acquisition, Highlands will provide its expertise and management services to Opera in return for a management fee of £20,000 per month.

 

Timetable

 

Highlands and Opera have already commenced work on the matters above and, in particular, the competent persons report commissioned with RPS Knowledge Reservoir is already well advanced. The parties will update their respective shareholders in due course but, at the present time, they expect that Opera will publish its shareholder documentation during the summer with its shareholder meeting being convened, and the Acquisition completing, shortly thereafter.

 

**ENDS**

 

For further information, please contact:

 

 

Highlands Natural Resources plc

Robert Price

+1 (0) 918 361 7000

Opera Investments plc

Paul Dudley

+44 (0) 20 3551 4872

Cenkos Securities plc

Neil McDonald

+44 (0)131 220 9771

Nick Tulloch

+44 (0)131 220 9772

St Brides Partners Ltd

Lottie Brocklehurst

+44 (0) 20 7236 1177

Elisabeth Cowell

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKPDQABKKNAD
Date   Source Headline
19th Aug 20191:40 pmRNSResult of AGM
19th Aug 20197:02 amRNSAGM Statement
19th Aug 20197:00 amRNSPlacing of New Shares
9th Aug 20197:00 amRNSCommencement of UK sales
2nd Aug 20192:05 pmRNSSecond Price Monitoring Extn
2nd Aug 20192:00 pmRNSPrice Monitoring Extension
2nd Aug 20197:00 amRNSAgreement to supply CBD to Cellulac plc
26th Jul 20192:05 pmRNSSecond Price Monitoring Extn
26th Jul 20192:00 pmRNSPrice Monitoring Extension
25th Jul 20197:00 amRNSFinal Results
1st Jul 20197:00 amRNSTrading Update
14th Jun 20197:00 amRNSLaunch of new CBD brand
6th Jun 20197:00 amRNSSubscription and Issue of Shares
28th May 20197:00 amRNSNew cannabinoid R&D collaboration
9th May 20197:00 amRNSTrading Update
26th Apr 20197:00 amRNSBoard Change Update
16th Apr 20197:00 amRNSBoard Change
1st Apr 20197:00 amRNSFirst Retail Sale Agreement - Zoetic Organics
26th Mar 20197:00 amRNSDisclosure of notifiable interests
20th Mar 20197:00 amRNSResults of PrimaryBid.com Offer
19th Mar 20194:31 pmRNSPrimaryBid.com Offer
19th Mar 20194:30 pmRNSFundraising for an Organic Cannabidiol Operation
25th Feb 20197:00 amRNSEast Denver Wells IP Rate Update
30th Jan 20195:40 pmRNSChange of Auditor
28th Jan 20197:00 amRNSGas Sales Commence at East Denver Project
14th Jan 20197:00 amRNSEight Producing Wells - East Denver
2nd Jan 20197:00 amRNSColorado Shale - East Denver Project Update
13th Dec 20187:00 amRNSInterim Results
20th Nov 20184:40 pmRNSSecond Price Monitoring Extn
20th Nov 20184:35 pmRNSPrice Monitoring Extension
20th Nov 20187:00 amRNSUpdate on Operations and Notice of Results
19th Nov 20189:05 amRNSSecond Price Monitoring Extn
19th Nov 20189:00 amRNSPrice Monitoring Extension
19th Nov 20187:00 amRNSColorado Shale - West Denver Update
12th Nov 20187:00 amRNSWest Denver Update
7th Nov 20187:00 amRNSUpdate Colorado Shale Operations
18th Oct 20187:00 amRNSColorado Shale - Permitting of West Denver Project
16th Oct 20187:00 amRNSHighlands Water Resources and Montana Update
25th Sep 20183:50 pmRNSReduction of Capital Approved
20th Sep 20187:00 amRNSColorado Shale - East Denver Operations Update
21st Aug 20182:38 pmRNSResult of AGM
21st Aug 20187:00 amRNSAGM Statement
24th Jul 20187:00 amRNSFinal Results
19th Jul 20187:00 amRNSEast Denver - Drilling Operations Complete
16th Jul 20185:42 pmRNSHolding(s) in Company
12th Jul 20188:01 amRNSIssue of Shares
11th Jul 201812:30 pmRNSCompletes acquisition of leases
4th Jul 20187:00 amRNSNotice of Results and Shareholder Call
29th Jun 20187:00 amRNSGas Analysis Update for Kansas Nitrogen Project
27th Jun 20187:00 amRNSEast Denver Project Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.